Becton, Dickinson and Co. | BDX - Cash And Equivalent

Stock Price
207.87
Daily Change
1.37 0.66%
Monthly
4.48%
Yearly
-15.18%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $641M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Agilent USD 1.79B 254M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Bio-Rad Laboratories USD 395.8M 26.5M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Dexcom USD 1.84B 676.7M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Exact Sciences USD 789.04M 131.94M Sep/2025
Globus Medical USD 229.45M 231.82M Jun/2025
Hologic USD 2.17B 208.5M Dec/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
J&J USD 18.23B 10.35B Sep/2025
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Solventum Corp USD 1.64B 1.15B Sep/2025
Stryker USD 3.26B 881M Sep/2025
Tandem Diabetes Care USD 91.95M 27.83M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
Terumo JPY 204.29B 17.58B Jun/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025